Sahar A. Sabry
Cairo, C, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Network Hypoactivity in ALG13-CDG: Disrupted Developmental Pathways and E/I Imbalance as Early Drivers of Neurological Features in CDG.
Journal: Cells
Published: November 29, 2025
Network Hypoactivity in ALG13-CDG: Disrupted Developmental Pathways and E/I Imbalance as Early Drivers of Neurological Features in CDG.
Journal: Cells
Published: November 29, 2025
ALG13 loss-of-function alters glycosylation, impairs neuronal maturation, and drives network hypoactivity in a cortical organoid model of CDG.
Journal: bioRxiv : the preprint server for biology
Published: August 12, 2025
An atypical expression of core α-Dystroglycan and Laminin-α2 in skin fibroblasts of patients with congenital muscular dystrophies.
Journal: Molecular biology reports
Published: February 16, 2023
Abnormal expression of lysosomal glycoproteins in patients with congenital disorders of glycosylation.
Journal: BMC research notes
Published: December 26, 2022
Sialic acid and anti-ganglioside M1 antibodies are invaluable biomarkers correlated with the severity of autism spectrum disorder.
Journal: Brain & development
Published: September 20, 2022
Mesenchymal Stem Cells Ameliorate Hyperglycemia in Type I Diabetic Developing Male Rats.
Journal: Stem cells international
Published: January 19, 2022
Fetal brain arrest broadens the spectrum of WDR81-related developmental brain malformations.
Journal: Neurogenetics
Published: June 13, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026